225 related articles for article (PubMed ID: 16166944)
21. Researcher makes breakthrough in cancer research.
Expert Rev Anticancer Ther; 2002 Feb; 2(1):7. PubMed ID: 12113070
[No Abstract] [Full Text] [Related]
22. Breast cancer vaccines: promise for the future or pipe dream?
Mittendorf EA; Peoples GE; Singletary SE
Cancer; 2007 Oct; 110(8):1677-86. PubMed ID: 17763371
[TBL] [Abstract][Full Text] [Related]
23. Current immunotherapeutic strategies in pancreatic cancer.
Plate JM
Surg Oncol Clin N Am; 2007 Oct; 16(4):919-43, xi. PubMed ID: 18022552
[TBL] [Abstract][Full Text] [Related]
24. Vaccines in leukemia.
Lu S; Wieder E; Komanduri K; Ma Q; Molldrem JJ
Adv Pharmacol; 2004; 51():255-70. PubMed ID: 15464913
[No Abstract] [Full Text] [Related]
25. Prospects for vaccine therapy for pancreatic cancer.
Gaudernack G
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):299-314. PubMed ID: 16549329
[TBL] [Abstract][Full Text] [Related]
26. Cancer immunotherapy targeting the telomerase reverse transcriptase.
Huo LF; Tang JW; Huang JJ; Huang PT; Huang CF; Kung HF; Lin MC
Cell Mol Immunol; 2006 Feb; 3(1):1-11. PubMed ID: 16549043
[TBL] [Abstract][Full Text] [Related]
27. [Cancer vaccines].
Kyte JA
Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2969-73. PubMed ID: 17117197
[TBL] [Abstract][Full Text] [Related]
28. Cancer vaccines: is there a future?
Streicher H
Expert Rev Vaccines; 2004 Dec; 3(6):617-9. PubMed ID: 15606342
[No Abstract] [Full Text] [Related]
29. Overview of tumor cell-based vaccines.
Copier J; Dalgleish A
Int Rev Immunol; 2006; 25(5-6):297-319. PubMed ID: 17169778
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic cancer vaccines on trial.
Reichert JM; Paquette C
Nat Biotechnol; 2002 Jul; 20(7):659-63. PubMed ID: 12089545
[No Abstract] [Full Text] [Related]
31. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
32. Cancer Vaccine Collaborative 2002: opening address.
Old LJ
Cancer Immun; 2003 Feb; 3 Suppl 1():1. PubMed ID: 12747742
[No Abstract] [Full Text] [Related]
33. Advances in the development of a therapeutic cancer vaccine.
Avigan D
J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S2-6. PubMed ID: 16280106
[No Abstract] [Full Text] [Related]
34. Cancer vaccines: training the immune system to fight cancer.
Meadows M
FDA Consum; 2004; 38(5):20-5. PubMed ID: 15595145
[No Abstract] [Full Text] [Related]
35. Heat shock proteins and their use as anticancer vaccines.
Parmiani G; Testori A; Maio M; Castelli C; Rivoltini L; Pilla L; Belli F; Mazzaferro V; Coppa J; Patuzzo R; Sertoli MR; Hoos A; Srivastava PK; Santinami M
Clin Cancer Res; 2004 Dec; 10(24):8142-6. PubMed ID: 15623587
[No Abstract] [Full Text] [Related]
36. Immunology and breast cancer: therapeutic cancer vaccines.
Curigliano G; Rescigno M; Goldhirsch A
Breast; 2007 Dec; 16 Suppl 2():S20-6. PubMed ID: 17706425
[TBL] [Abstract][Full Text] [Related]
37. Cancer vaccines. The quest heats up.
Mayo Clin Health Lett; 2012 Apr; 30(4):4-5. PubMed ID: 22649817
[No Abstract] [Full Text] [Related]
38. DNA vaccines: successes and limitations in cancer and infectious disease.
Lowe DB; Shearer MH; Kennedy RC
J Cell Biochem; 2006 May; 98(2):235-42. PubMed ID: 16440328
[TBL] [Abstract][Full Text] [Related]
39. Cancer vaccines: preclinical studies and novel strategies.
Palena C; Abrams SI; Schlom J; Hodge JW
Adv Cancer Res; 2006; 95():115-45. PubMed ID: 16860657
[TBL] [Abstract][Full Text] [Related]
40. Overcoming technical challenges in the development of cancer vaccines.
Dalgleish A
IDrugs; 2007 Jul; 10(7):463-7. PubMed ID: 17642016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
